07:46 AM EDT, 08/13/2025 (MT Newswires) -- Shineco ( SISI ) said Wednesday it created a Biological Cell Digital Business Division to integrate its cell technology operations with blockchain systems.

The new division will design a blockchain platform to manage and verify cell assets, establish an induced pluripotent stem cell bank, and introduce equity transfer mechanisms to improve asset circulation, the company said.

The initiatives aim to help medical and research institutions manage resources more effectively, reduce barriers for users, strengthen health data oversight, and add artificial intelligence tools to their services, Shineco ( SISI ) said.

The company also said Lin Hongguang, former chief researcher at the Korea Digital Currency Research Institute, will work as general manager, leading strategy, daily operations, and global collaboration.

Shares of the company were down by more than 5% in recent Wednesday premarket activity.